This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

RLH Equity Partners Portfolio Company, Cymetrix Corporation, Acquired By Navigant

LOS ANGELES, May 15, 2014 /PRNewswire/ -- Riordan, Lewis & Haden | Equity Partners (RLH) is pleased to announce that its portfolio company, Cymetrix Corporation (the "Company"), has been acquired by Navigant (NYSE: NCI).

Cymetrix is a leading national provider of comprehensive revenue cycle management solutions to hospitals and their affiliated physicians. The Company helps its clients achieve sustained improvement in financial performance while maintaining a high quality patient experience. Serving over 200 hospitals nationwide, Cymetrix deploys technology, best-practice workflows, and operational expertise to create a custom solution for each client across the entire revenue cycle - patient access services, health information management, and patient financial services.

Navigant is a specialized, global expert services firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. Within the healthcare sector, Navigant works with payers and providers to design, develop, and implement integrated, technology-enabled solutions that create high-performing healthcare organizations. Navigant's healthcare consultants assist clients with issues including quality of care, cost, leadership, and culture in today's changing healthcare environment.

RLH is exceptionally proud of Cymetrix's success in transforming its offerings from specific services for individual elements of the hospital revenue cycle into highly integrated end-to-end solutions. As part of that success, the Company developed unique proprietary software that provides real-time transparency into the performance of the client's revenue cycle and the value created by Cymetrix's services. The Company has received much well-deserved recognition, including two consecutive years of Best in KLAS awards for Extended Business Office Services and the highest score in the recent report, "Best in KLAS Awards: Software & Services." We congratulate CEO Michael Halberda and the entire Cymetrix organization on their achievements and their contribution to the accomplishment of their clients' healing mission, and wish the Company continued success in the future as part of the Navigant team.

About RLH

Riordan, Lewis & Haden is a leading private equity firm which partners with entrepreneurs to help them build distinctive high-growth businesses and realize their aspirations. RLH provides experienced strategic guidance to its portfolio companies while embracing the entrepreneurial spirit of those companies' founders. The RLH team, which averages 17 years of private equity experience, has developed proven processes to enhance organic growth and drive enterprise value. With a 30+ year history of successful investing, RLH is uniquely able to help fast growing enterprises with $25-150 million revenue in the business services, healthcare, and government services sectors achieve their goals. The firm currently manages over $600 million of assets and is actively seeking new portfolio company investments.

ContactFor more information please contact:

J. Christopher LewisManaging PartnerRiordan, Lewis & Haden | Equity Partners 310-405-7200 clewis@rlhequity.com www.rlhequity.com

SOURCE Riordan Lewis & Haden | Equity Partners

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,098.29 +74.23 0.41%
S&P 500 2,117.34 +9.05 0.43%
NASDAQ 5,028.9360 +23.5450 0.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs